The Flow Cytometry Facility serves the UCCRC members by providing access to state-of-the-art technology, and quantitative analytical approaches to measure molecular and cellular function. The Facility is designed to meet the wide-spread needs for specialized cytologic analysis, and continues to respond to the demand for new and improved technology. The Facility's mission is three-fold: 1) To provide cutting-edge technology and expertise; 2) To pursue technology and application development;and 3) To provide education and training of researchers. The first goal is attained with state-of-the-art instrumentation and continuing education for the expert personnel. Technology and application development involves close relationships with Cancer Research Center researchers who are continually looking for new methods to address their scientific questions. Educational goals are satisfied by providing application workshops, training sessions, and one-on-one protocol development and consultation. The Facility also provides an extensive reference library containing references pertinent to its technological focus. The Facility's Scientific Director (Dr. Anne Sperling) and Technical Director (Mr. Ryan Duggan) provide direct oversight of the operation of the Flow Cytometry Facility. A Faculty Advisory Committee (FAC) is advisory to the Facility personnel with regards to services, scientific direction, and fiscal issues. The Facility is utilized by UCCRC investigators in many areas of study involved in the basic research of cellular function. The Flow Cytometry Facility provides instrumentation for the analytical detection of subcellular components using multiparametric fluorescence detection technology. Another key component of the Facility is its cell sorting instruments that allow the fractionation and purification of subpopulations of cells from a heterogeneous single cell suspension. The Flow Cytometry Facility has increased its cell sorting and bench-top analyzer capacity to meet investigator demand, resulting in more than a 300% increase in overall Facility usage since the 2001 CCSG renewal. Over 52 peerreviewed UCCRC investigators across five Scientific Programs routinely use the Flow Cytometry Facility, totaling 80% of Facility usage.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-35
Application #
8105367
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
35
Fiscal Year
2010
Total Cost
$180,243
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Zeineddine, Hussein A; Girard, Romuald; Saadat, Laleh et al. (2018) Phenotypic characterization of murine models of cerebral cavernous malformations. Lab Invest :
Kane, Melissa; Deiss, Felicity; Chervonsky, Alexander et al. (2018) A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses. J Virol 92:
Xiao, Annie; Crosby, Jennie; Malin, Martha et al. (2018) Single-institution report of setup margins of voluntary deep-inspiration breath-hold (DIBH) whole breast radiotherapy implemented with real-time surface imaging. J Appl Clin Med Phys 19:205-213
Gamazon, Eric R; Trendowski, Matthew R; Wen, Yujia et al. (2018) Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma. Sci Rep 8:733
Girard, Romuald; Zeineddine, Hussein A; Koskimäki, Janne et al. (2018) Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res 122:1716-1721
Day, Kasey J; Casler, Jason C; Glick, Benjamin S (2018) Budding Yeast Has a Minimal Endomembrane System. Dev Cell 44:56-72.e4
Pu, Jinyue; Kentala, Kaitlin; Dickinson, Bryan C (2018) Multidimensional Control of Cas9 by Evolved RNA Polymerase-Based Biosensors. ACS Chem Biol 13:431-437
Pectasides, Eirini; Stachler, Matthew D; Derks, Sarah et al. (2018) Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov 8:37-48
Liu, Hongtao; Zha, Yuanyuan; Choudhury, Noura et al. (2018) WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia. Exp Hematol Oncol 7:1
Nageeb, Shaheen; Vu, Milkie; Malik, Sana et al. (2018) Adapting a religious health fatalism measure for use in Muslim populations. PLoS One 13:e0206898

Showing the most recent 10 out of 668 publications